Advances in indolo[2,3-a]carbazole chemistry: Design and synthesis of protein kinase C and topoisomerase I inhibitors

Current Medicinal Chemistry

Volumn 6, Issue 1, 1999, Pages 29-69

  Pindur, Ulf ^a   Kim, Young Shin ^a   Mehrabani, Farokh ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBAZOLE DERIVATIVE; DNA TOPOISOMERASE; DNA TOPOISOMERASE INHIBITOR; INDOLO[2,3 A]CARBAZOLE; NATURAL PRODUCT; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; DRUG DESIGN; DRUG SYNTHESIS; MOLECULAR MODEL; REVIEW; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY;

ANTINEOPLASTIC AGENTS; CARBAZOLES; DNA TOPOISOMERASES, TYPE I; INDOLES; MALEIMIDES; PROTEIN KINASE C; PYRROLES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032936474     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. Gribble, G.W.; Berthel, S.J. A survey of indolo[2,3-a]carbazole alkaloids and related natural products in Studies in Natural Products Chemistry, Atta-ur-Rahman (ed.), 1993, 12, 365-409.
2. Bergman, J.; Koch, E.; Pelcman, B. Tetrahedron Lett. 1995, 36, 3945-3948.
3. Vice, S.F.; Bishop, W.R.; McCombie, S.W.; Dao, H.; Frank, E.; Ganguly, A.K. Bioorganic & Medicinal Chemistry Lett. 1994, 11, 1333-1338.
4. Davis, P.D.; Hallam, T.J.; Harris, W.; Hill, C.H.; Lawton, G.; Nixon, J.S.; Smith, J.L.; Vesey, D.R.; Wilkinson, S.E. Bioorganic & Medicinal Chemistry Lett. 1994, 4, 1303-1308.
5. Kase, H.; Iwahashi, K.; Matsuda, Y. J. Antibiotics 1986, 39, 1059-1065.
6. Hirayama, N.; Iida, T.; Shirahata, K. Acta Crystallogr. 1986, C42, 1402-1404.
7. Furusaki, A.; Hashiba, N.; Matsumoto, T.; Hirano, A.; Iwai, Y.; Omura, S. J. Chem. Soc., Chem. Commun. 1978, 800-801; Funato, N.; Takajanagi, H.; Konda, Y.; Toda, Y.; Harigaya, Y.; Iwai, Y.; Omura S. Tetrahedron Lett. 1994, 35, 1351.
8. Furusaki, A.; Hashiba, N.; Matsumoto, T.; Hirano, A.; Iwai, Y.; Omura, S. J. Chem. Soc., Chem. Commun. 1978, 800-801; Funato, N.; Takajanagi, H.; Konda, Y.; Toda, Y.; Harigaya, Y.; Iwai, Y.; Omura S. Tetrahedron Lett. 1994, 35, 1351.
9. Kinnel, R.B.; Scheuer, P.J. J. Org. Chem. 1992, 57, 6327.
10. Tsubotani, S.; Tanida, S.; Harada, S. Tetrahedron 1991, 47, 3565-3574.
11. Steglich, W.; Steffan, B.; Kopanski, L.; Eckhardt, G. Angew. Chem. (Int. Ed. Engl.) 1980, 19, 459.
12. Bonjouklian, R.; Smitka, T.A.; Doolin, L.E.; Molloy, R.M.; Debono, M.; Shaffer, S.A.; Moore, R.E.; Stewart, J.B.; Patterson, G.M.L. Tetrahedron 1991, 47, 7739-7750.
13. Nettleton, D.E.; Soyle, T.W.; Krishnan, B.; Matsumoto, G.K.; Clardy, J. Tetrahedron Lett. 1985, 26, 4011-4014.
14. Kase, H.; Iwahashi, K.; Nakanishi, S.; Matsuda, Y.; Yamada, K.; Takahashi, M.; Murakata, C.; Sato, A.; Kaneko, M. Biochem. Biophys. Res. Commun. 1987, 142, 436.
15. Tamaoki, T. Methods in Enzymology 1992, 201, 340; Nishizuka, Y. Methods in Enzymology 1983, 99, 288; Nishizuka, Y. Nature 1988, 334, 661-668.
16. Tamaoki, T. Methods in Enzymology 1992, 201, 340; Nishizuka, Y. Methods in Enzymology 1983, 99, 288; Nishizuka, Y. Nature 1988, 334, 661-668.
17. Tamaoki, T. Methods in Enzymology 1992, 201, 340; Nishizuka, Y. Methods in Enzymology 1983, 99, 288; Nishizuka, Y. Nature 1988, 334, 661-668.
18. Tamaoki, T.; Nomoto, H.; Takahashi, I.; Kato, Y.; Morimoto, M.; Tomita, F. Biochem. Biophys. Res. Commun. 1986, 135, 397.
19. Fujita-Yamaguchi, Y.; Kathuria, S. Biochem. Biophys. Res. Commun. 1988, 157, 955.
20. Lam, K.S.; Schroeder, D.R.; Veith, J.M.; Matson, J.A.; Forenza, S. J. Antibiotics 1991, 44, 934; Kaneko, T.; Wong, H.S.; Utzig, J.J. European Patent 0269025, 1988; Chem. Abstr. 1989, 110, 135647.
21. Lam, K.S.; Schroeder, D.R.; Veith, J.M.; Matson, J.A.; Forenza, S. J. Antibiotics 1991, 44, 934; Kaneko, T.; Wong, H.S.; Utzig, J.J. European Patent 0269025, 1988; Chem. Abstr. 1989, 110, 135647.
22. Lam, K.S.; Schroeder, D.R.; Veith, J.M.; Matson, J.A.; Forenza, S. J. Antibiotics 1991, 44, 934; Kaneko, T.; Wong, H.S.; Utzig, J.J. European Patent 0269025, 1988; Chem. Abstr. 1989, 110, 135647.
23. Davis, P.D.; Elliott, L.H.; Harris, W.; Hill, C.H.; Hurst, S.A.; Keech, E.; Kumar, M.K.H.; Lawton, G.; Nixon, J.S.; Wilkinson, S.E. J. Med. Chem. 1992, 35, 994-1001.
24. Hendricks, R.T.; Sherman, D.; Strulovici, B.; Broka, C.A. Bioorganic & Medicinal Chemistry Lett. 1995, 5, 67-72.
25. Xie, G.; Zimmermann, J.; Meyer, T.; Lown, J.W. Bioorganic & Medicinal Chemistry Lett. 1995, 5, 497-500.
26. Nixon, J.S.; Bishop, J.; Bradshaw, D.; Davis, P.D.; Hill, C.H.; Elliott, L.H.; Kumar, H.; Lawton, G.; Lewis, E.J.; Mulqueen, M.; Westmacott, D.; Wadsworth, J.; Wilkinson, S.E. Biochem. Soc. Trans 1992, 419-424. Danso, D.; Harmon, C.; Spriggs, D.; Kelsen, D.K.; Schwartz, G.K. Proc. Amer. Assoc. Cancer Res. 1997, 38, 619.
27. Nixon, J.S.; Bishop, J.; Bradshaw, D.; Davis, P.D.; Hill, C.H.; Elliott, L.H.; Kumar, H.; Lawton, G.; Lewis, E.J.; Mulqueen, M.; Westmacott, D.; Wadsworth, J.; Wilkinson, S.E. Biochem. Soc. Trans 1992, 419-424. Danso, D.; Harmon, C.; Spriggs, D.; Kelsen, D.K.; Schwartz, G.K. Proc. Amer. Assoc. Cancer Res. 1997, 38, 619.
28. Anizon, F.; Belin, L.; Moreau, P.; Sancelme, M.; Voldoire, A.; Prudhomme, M.; Ollier, M.; SevËre, D.; Riou, J.-F.; Bailly, C.; Fabbro, D.; Meyer, T. J. Med. Chem. 1997, 40, 3456-3465.
29. Yoshinari, T.; Matsumoto, M.; Arakawa, H.; Okada, H.; Noguchi, K.; Suda, K.; Okura, A.; Nishimura, S. Canc. Res. 1995, 55, 1310-1315; for an actual review of topoisomerase inhibitors see: Wang, H.-K.; Morris-Natschke, S.L.; Lee, K.-H. Med. Res. Rev. 1997, 17, 367-425.
30. Yoshinari, T.; Matsumoto, M.; Arakawa, H.; Okada, H.; Noguchi, K.; Suda, K.; Okura, A.; Nishimura, S. Canc. Res. 1995, 55, 1310-1315; for an actual review of topoisomerase inhibitors see: Wang, H.-K.; Morris-Natschke, S.L.; Lee, K.-H. Med. Res. Rev. 1997, 17, 367-425.
31. Bergman, J. Stud. Nat. Prod. Chem., Atta-ur-Rahman (ed.), Part A 1988, 1, 3.
32. Hartenstein, J. H.; Aranda, J.; Barth, H.; Betche, H.J.; Kleinschroth, J.; Reck, R.; Rudolph, C.; Trostmann, U.; Schächtele, C. The design of protein kinase C inhibitors in Perspectives in Medicinal Chemistry, Testa, B.; Kyburz, E.; Fuhrer, W.; Giger, R. (eds.) VCH-Verlag, Weinheim, Verlag Helvetica Chimica Acta, Basel, 1993, 101-118; for the new indolocarbazole Ĝ 6976 see Martiny-Baron, G.; Kazanietz, M.G.; Mischak, H.; Blumberg, P.M.; Kochs, G.; Hug, H.; MarmÈ, D.; Schächtele, C. J. Biol. Chem. 1993, 268, 9194-9197.
33. Hartenstein, J. H.; Aranda, J.; Barth, H.; Betche, H.J.; Kleinschroth, J.; Reck, R.; Rudolph, C.; Trostmann, U.; Schächtele, C. The design of protein kinase C inhibitors in Perspectives in Medicinal Chemistry, Testa, B.; Kyburz, E.; Fuhrer, W.; Giger, R. (eds.) VCH-Verlag, Weinheim, Verlag Helvetica Chimica Acta, Basel, 1993, 101-118; for the new indolocarbazole Ĝ 6976 see Martiny-Baron, G.; Kazanietz, M.G.; Mischak, H.; Blumberg, P.M.; Kochs, G.; Hug, H.; MarmÈ, D.; Schächtele, C. J. Biol. Chem. 1993, 268, 9194-9197.
34. Kleinschroth, J.; Hartenstein, J.; Rudolph, C.; Schächtele, C. Bioorganic & Medicinal Chemistry Lett. 1993, 1959-1964; Steglich, W., Fortschr. Chem. Org. Naturst. 1987, 51, 216; Steglich, W. Pure Appl. Chem. 1988, 61, 281.
35. Kleinschroth, J.; Hartenstein, J.; Rudolph, C.; Schächtele, C. Bioorganic & Medicinal Chemistry Lett. 1993, 1959-1964; Steglich, W., Fortschr. Chem. Org. Naturst. 1987, 51, 216; Steglich, W. Pure Appl. Chem. 1988, 61, 281.
36. Kleinschroth, J.; Hartenstein, J.; Rudolph, C.; Schächtele, C. Bioorganic & Medicinal Chemistry Lett. 1993, 1959-1964; Steglich, W., Fortschr. Chem. Org. Naturst. 1987, 51, 216; Steglich, W. Pure Appl. Chem. 1988, 61, 281.
37. Omura, S.; Sasaki, Y.; Iwai, Y.; Takeshima, H. J. Antibiotics 1995, 48, 535.
38. Sezaki, M.; Sasaki, T.; Nakazawa, T.; Takeda, U.; Iwata, M.; Watanabe, T.; Koyama, M.; Kai, F.; Shomura, T.; Kojima, M. J. Antibiotics 1985, 38, 1437.
39. Harris, W.; Hill, C.H.; Lewis, E.J.; Nixon, J.S.; Wilkinson, S.E. Drugs of the Future 1993, 18, 727-735.
40. Wang, H.-K.; Morris-Natschke, S.L.; Lee, K.-H. Med. Res. Rev. 1997, 17, 367-425.
41. Wood, J.L.; Stoltz, B.M.; Dietrich, H.-J. J. Am. Chem. Soc. 1995, 117, 10413-10414.
42. Wood, J.L.; Stoltz, B.M.; Dietrich, H.-J.; Pflum, D.A.; Petsch, D.T. J. Am. Chem. Soc. 1997, 119, 9641-9651.
43. Wood, J.L.; Stoltz, B.M.; Goodman, S.N.; Onwueme, K. J. Am. Chem. Soc. 1997, 119, 9652-9661.
44. Funato, N.; Takayanagi, H.; Konda, Y.; Toda, Y.; Harigaya, Y.; Iwai, Y.; Omura, S. Tetrahedron Lett. 1994, 35, 1251-1254.
45. Link, J.T.; Raghavan, S.; Danishefsky, S.J. J. Am. Chem. Soc. 1995, 117, 552-553.
46. Link, J.T.; Danishefsky, S.J. Tetrahedron Lett. 1994, 35, 9131-9134.
47. Gallant, M.; Link, J.T.; Danishefsky, S.J. J. Org. Chem. 1993, 58, 343-349.
48. Shankar, B.B.; Viet, A.Q.; Rizvi, R.; Kirkup, M.P.; McCombie, S.W.; Ganguly, A.K. Bioorganic & Medicinal Chemistry Lett. 1994, 4, 485-498.
49. a) Somei, M.; Kodama, A. Heterocycles 1992, 34, 1285-1288. b) For new synthetic developments of 2,2í-bisindolyl and 3,3í-functionalized derivatives see: Bergman, J.; Koch, E.; Pelcman, B. Tetrahedron 1995, 51, 5631-5642.
50. a) Somei, M.; Kodama, A. Heterocycles 1992, 34, 1285-1288. b) For new synthetic developments of 2,2í-bisindolyl and 3,3í-functionalized derivatives see: Bergman, J.; Koch, E.; Pelcman, B. Tetrahedron 1995, 51, 5631-5642.
51. Pindur, U. Cycloaddition reactions of indole derivatives in Adv. Nitrogen Heterocycles, Moody, C.J. (ed.) Vol. 1, JAI Press, Greenwich, CT, pp 121, 1995.
52. Barry, J.F.; Wallace, T.W.; Walshe, N.D.A. Tetrahedron 1995, 51, 12797-12806.
53. Pindur, U.; Kim, Y.-S.; Schollmeyer, D. J. Heterocyclic Chem. 1994, 31, 377-386.
54. Pindur, U.; Kim, Y.-S. J. Heterocyclic Chem. 1996, 33, 623-631.
55. Pindur, U.; Kim, Y.-S.; Schollmeyer, D. J. Heterocyclic Chem. 1995, 32, 1335-1339.
56. Pindur, U.; Kim, Y.-S., Schollmeyer, D. Heterocycles 1994, 38, 2267-2276.
57. Schollmeyer, D.; Kim, Y.-S.; Pindur, U. Z. Naturforsch. 1997, 52b, 1251-1258. Pindur, U.; Kim, Y.-S., J. Heterocyclic Chem. 1998, 35, 97-101.
58. Schollmeyer, D.; Kim, Y.-S.; Pindur, U. Z. Naturforsch. 1997, 52b, 1251-1258. Pindur, U.; Kim, Y.-S., J. Heterocyclic Chem. 1998, 35, 97-101.
59. Furet, P.; Caravatti, G.; Lydon, N.; Priestle, J.P.; Sowadski, J.M.; Trinks, U.; Traxler, P. J. Comp.-Aid. Molec. Design 1995, 9, 465-472.
60. Pindur, U.; Lemster, T. Recent advances in the synthesis of carbazoles and anellated indoles with antitumor activity: DNA-binding ligands and protein kinase C inhibitors in Organic and Bioorganic Chemistry, 1997, 1, 33-53.
61. Fabre, S.; Prudhomme, M.; Sancelme, M.; Rapp, M. Bioorganic & Medicinal Chemistry Lett. 1994, 2, 73-77.
62. McCombie, S.W.; Bishop, R.W.; Carr, D.; Dobek, E.; Kirkup, M.P.; Kirschmeier, P.; Lin, S.-I.; Petrin, J.; Rosinski, K.; Shankar, B.B.; Wilson, O. Bioorganic & Medicinal Chemistry Lett. 1993, 3, 1537-1542.
63. For the first synthesis of arcyriaflavin-A see: Gill, M.; Steglich, W. Prog. Chem. Org. Nat. Prod. 1987, 51.
64. Fonseca, A.P.; Lobo, A.M.; Prabhakar, S. Tetrahedron Lett. 1995, 36, 2689-2692.
65. Kleinschroth, J.; Hartenstein, J.; Rudolph, C.; Schächtele, C. Bioorganic & Medicinal Chemistry Lett. 1995, 5, 55-60.
66. He, M.; Buisine, E.; Tartar, A.T.; Sergheraert, C. Bioorganic & Medicinal Chemistry Lett. 1994, 4, 2845-2850.
67. Sasaki, S.; Mizushima, T.; Hashimoto, T.; Maeda, M.; Sekimizu, K. Bioorganic & Medicinal Chemistry Lett. 1994, 4, 1771-1774.
68. Somei, M.; Hayashi, H.; Izumi, T.; Ohmoto, S. Heterocycles 1995, 41, 2161-2164.
69. Mayer, G.; Wille, G.; Steglich, W. Tetrahedron Lett. 1996, 37, 4483-4486.
70. Saulnier, M.G.; Frennesson, D.B.; Deshpande, M.S.; Vyas, D.M. Tetrahedron Lett. 1996, 43, 7841-7844.
71. Faul, M.M.; Sullivan, K.A.; Winneroski, L.L. Synthesis 1995, 1511-1516.
72. McCombie, S.W.; Vice, S.F. J. Org. Chem. 1996, 61, 413-415.
73. Yamada, R.; Seto, M.; Sasaki, Y.; Sunazuka, T.; Harigaya, Y.; Iwai, Y.; Omura, S. J. Antibiotics. 1996, 49, 1070-1072.
74. Ohkubo, M.; Nishimura, T.; Jona, H.; Honma, T.; Morishima, H. Tetrahedron 1996, 52, 8099-8112.
75. Fredenhagen, A.; Peter, H.H. Tetrahedron 1996, 52, 1235-1238.
76. Hudkins, R.L.; Diebold, J.L. Tetrahedron Lett. 1997, 38, 915-918.
77. Rodrigues Pereira, E.; Prudhomme, M.; Sancelme, M.; Ollier, M.; Severe, D.; Riou, J.F.; Crevel, H.; Savineau, J.P.; Fabbro, D.; Meyer, T. Chem. Pharm. Bull. 1997, 4, 733-736.
78. Ohkubo, M.; Kawamoto, H.; Ohno, T.; Nakano, M.; Morishima, H. Tetrahedron 1997, 53, 585-592.
79. Lowinger, T.B.; Chu, J.; Spence, P.L. Tetrahedron Lett. 1995, 36, 8383-8386.
80. Rodrigues Pereira, E.; Fabre, S.; Sancelme, M.; Prudhomme, M.; Rapp, M. J. Antibiotics 1995, 48, 863-868.
81. Jirousek, M.R.; Faul, M.M.; Melikian-Badalian, A. Bioorganic & Medicinal Chemistry Lett. 1995, 5, 2093-2096.
82. Harris, W.; Hill, C.H.; Keech, E.; Malsher, P. Tetrahedron Lett. 1993, 51, 8361-8364.
83. a) Merlic, C. A.; McInnes, D.M. Tetrahedron Lett. 1997, 38, 7661-7664. b) Merlic, C. A.; McInnes, D.M.; You, Y. Tetrahedron Lett. 1997, 39, 6787-6790.
84. a) Merlic, C. A.; McInnes, D.M. Tetrahedron Lett. 1997, 38, 7661-7664. b) Merlic, C. A.; McInnes, D.M.; You, Y. Tetrahedron Lett. 1997, 39, 6787-6790.
85. Neel, D.A.; Jirousek, M.R.; McDonald, J.H. Bioorganic & Medicinal Chemistry Lett. 1998, 8, 47-50.
86. Xie, G.; Lown, J.W. Tetrahedron Lett. 1994, 35, 5555-5558.
87. Pindur, U.; Lemster, T. Die Pharmazie 1998, 53, 79-86.
88. Xie, G.; Gupta, R.; Atchison, K.; Lown, J.W. J. Med. Chem. 1996, 39, 1049-1055.
89. Toledo, L.M.; Lydon, N.B. Structure 1997, 5, 1551-1556.
90. Prade, L.; Richard, A. E.; Girod, A.; Kinzel, V.; Huber, R.; Bossemeyer, D. Structure 1997, 5, 1627-1637.
91. Lawri, A.M.; Noble, M.E.M.; Tunnah, P.; Brown, N.R.; Johnson, L.N.; Endicott, J.A.E. Nature Struct. Biol. 1997, 4, 796-801.
92. Prudhomme, M. Curr. Pharm. Des. 1997, 3, 265-290.